Rein Therapeutics Inc. (RNTX)

Last Closing Price: 1.02 (2026-06-03)

Gross Margin (Quarterly)

Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues

Rein Therapeutics Inc. (RNTX) Gross Margin data is not available.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
--
$-5.84M
--
--
$5.23M
$-5.23M
$-0.61M
$-5.84M
$-5.84M
$-5.84M
$-5.84M
$-5.84M
$-5.84M
$-5.23M
$-4.61M
30.36M
30.36M
$-0.19
$-0.19
Balance Sheet Financials
$5.45M
--
$20.84M
$26.29M
$13.64M
--
$46.06M
$59.70M
$-33.41M
$-53.24M
$-33.41M
28.04M
Cash Flow Statement Financials
$-3.42M
--
$4.65M
$3.21M
$4.45M
$1.23M
$0.16M
--
--
Fundamental Metrics & Ratios
0.40
--
--
--
-0.15
Gross Margin
--
--
--
--
--
--
$-3.42M
--
--
--
--
--
--
--
17.47%
10.96%
-22.21%
17.47%
$-1.19
$-0.11
$-0.11